158 related articles for article (PubMed ID: 36723611)
1. Adverse effects following botulinum toxin A injections in children with cerebral palsy.
Sapienza M; Kapoor R; Alberghina F; Maheshwari R; McCracken KL; Canavese F; Johari AN
J Pediatr Orthop B; 2023 Sep; 32(5):435-451. PubMed ID: 36723611
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
Lukban MB; Rosales RL; Dressler D
J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
[TBL] [Abstract][Full Text] [Related]
3. Questionnaire about the adverse events and side effects following botulinum toxin A treatment in patients with cerebral palsy.
Blaszczyk I; Foumani NP; Ljungberg C; Wiberg M
Toxins (Basel); 2015 Nov; 7(11):4645-54. PubMed ID: 26561833
[TBL] [Abstract][Full Text] [Related]
4. Severity of cerebral palsy and likelihood of adverse events after botulinum toxin A injections.
Swinney CM; Bau K; Burton KLO; O'Flaherty SJ; Bear NL; Paget SP
Dev Med Child Neurol; 2018 May; 60(5):498-504. PubMed ID: 29451702
[TBL] [Abstract][Full Text] [Related]
5. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
6. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
Lorin K; Forsberg A
Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
[TBL] [Abstract][Full Text] [Related]
7. IncobotulinumtoxinA Efficacy/Safety in Upper-Limb Spasticity in Pediatric Cerebral Palsy: Randomized Controlled Trial.
Dabrowski E; Chambers HG; Gaebler-Spira D; Banach M; Kaňovský P; Dersch H; Althaus M; Geister TL; Heinen F
Pediatr Neurol; 2021 Oct; 123():10-20. PubMed ID: 34339951
[TBL] [Abstract][Full Text] [Related]
8. Systemic adverse events after botulinum neurotoxin A injections in children with cerebral palsy.
Paget SP; Swinney CM; Burton KLO; Bau K; O'Flaherty SJ
Dev Med Child Neurol; 2018 Nov; 60(11):1172-1177. PubMed ID: 30146721
[TBL] [Abstract][Full Text] [Related]
9. Upper extremity spasticity in children with cerebral palsy: a randomized, double-blind, placebo-controlled study of the short-term outcomes of treatment with botulinum A toxin.
Koman LA; Smith BP; Williams R; Richardson R; Naughton M; Griffin L; Evans P
J Hand Surg Am; 2013 Mar; 38(3):435-46.e1. PubMed ID: 23428186
[TBL] [Abstract][Full Text] [Related]
10. Botulinum Toxin Type A injections for pediatric spasticity: Keeping our patients informed and practices safe.
Wright E; Fetsko L
J Pediatr Rehabil Med; 2021; 14(2):199-211. PubMed ID: 34057107
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
12. High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy.
Intiso D; Simone V; Di Rienzo F; Iarossi A; Pazienza L; Santamato A; Maruzzi G; Basciani M
NeuroRehabilitation; 2014; 34(3):515-22. PubMed ID: 24473245
[TBL] [Abstract][Full Text] [Related]
13. Safety of Botulinum Toxin Type A for Children With Nonambulatory Cerebral Palsy.
Edwards P; Sakzewski L; Copeland L; Gascoigne-Pees L; McLennan K; Thorley M; Kentish M; Ware R; Boyd RN
Pediatrics; 2015 Nov; 136(5):895-904. PubMed ID: 26482662
[TBL] [Abstract][Full Text] [Related]
14. A risk-stratified approach toward safely resuming OnabotulinumtoxinA injections based on dosing and ambulatory status in pediatric patients with cerebral palsy during the Coronavirus pandemic of 2019 (COVID-19).
McLaughlin MJ; Fisher MT; Vadivelu S; Ramsey J; Ratnasingam D; McGhee E; Hartman K
J Pediatr Rehabil Med; 2020; 13(3):273-279. PubMed ID: 33252098
[TBL] [Abstract][Full Text] [Related]
15. Botulinum Toxin A Injection in Treatment of Upper Limb Spasticity in Children with Cerebral Palsy: A Systematic Review of Randomized Controlled Trials.
Farag SM; Mohammed MO; El-Sobky TA; ElKadery NA; ElZohiery AK
JBJS Rev; 2020 Mar; 8(3):e0119. PubMed ID: 32224633
[TBL] [Abstract][Full Text] [Related]
16. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
17. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin A for nonambulatory children with cerebral palsy: a double blind randomized controlled trial.
Copeland L; Edwards P; Thorley M; Donaghey S; Gascoigne-Pees L; Kentish M; Cert G; Lindsley J; McLennan K; Sakzewski L; Boyd RN
J Pediatr; 2014 Jul; 165(1):140-146.e4. PubMed ID: 24630348
[TBL] [Abstract][Full Text] [Related]
19. Safety of botulinum toxin A in children and adolescents with cerebral palsy in a pragmatic setting.
Papavasiliou AS; Nikaina I; Foska K; Bouros P; Mitsou G; Filiopoulos C
Toxins (Basel); 2013 Mar; 5(3):524-36. PubMed ID: 23482250
[TBL] [Abstract][Full Text] [Related]
20. Safety and Efficacy of a Propofol and Ketamine Based Procedural Sedation Protocol in Children with Cerebral Palsy Undergoing Botulinum Toxin A Injections.
Louer R; McKinney RC; Abu-Sultaneh S; Lutfi R; Abulebda K
PM R; 2019 Dec; 11(12):1320-1325. PubMed ID: 30761757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
